AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

This study is currently recruiting patients.

Sponsored by:University of Chicago
Information provided:National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:NCT00309946

Purpose:

RATIONALE: AZD2171 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

PURPOSE: This phase II trial is studying how well AZD2171 works in treating patients with malignant mesothelioma that cannot be removed by surgery.

Condition Intervention Phase
Malignant Mesothelioma
Drug: cediranib maleate
Other: laboratory biomarker analysis
Phase 2

Eligibility

Study Design: Masking: Open Label, Primary Purpose: Treatment

Official Title: Phase II Study of AZD2171 (NSC#732208) in Patients With Malignant Mesothelioma

Enrollment Size: Female

Gender: 18 Years

Min. Age: N/A

Max. Age: No

Location and Contact Information

United States, California
Tower Cancer Research Foundation, Beverly Hills, California, 90211-1850, United States
Status: Recruiting
Philomena F. McAndrew, MD 310-888-8680

United States, California
City of Hope Comprehensive Cancer Center, Duarte, California, 91010-3000, United States
Status: Recruiting
Clinical Trials Office - City of Hope Comprehensive Cancer Cen 800-826-4673 becomingapatient@coh.org

United States, California
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90089-9181, United States
Status: Recruiting
Clinical Trials Office - USC/Norris Comprehensive Cancer Cente 323-865-0451

United States, California
Contra Costa Regional Medical Center, Martinez, California, 94553, United States
Status: Recruiting
Sharon Hiner, MD 925-370-5114 shiner@hsd.co.contra-costa.ca.us

United States, California
City of Hope Medical Group, Pasadena, California, 91105, United States
Status: Recruiting
Mark V. McNamara, MD 626-396-2900 mmcnamara@ccsmg.com

United States, California
University of California Davis Cancer Center, Sacramento, California, 95817, United States
Status: Recruiting
Clinical Trials Office - University of California Davis Cancer 916-734-3089

United States, Illinois
University of Chicago Cancer Research Center, Chicago, Illinois, 60637-1470, United States
Status: Recruiting
Clinical Trials Office - University of Chicago Cancer Research 773-834-7424

United States, Illinois
Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, 62526, United States
Status: Recruiting
Clinical Trials Office - Decatur Memorial Hospital Cancer Care 217-876-4750

United States, Illinois
Evanston Hospital, Evanston, Illinois, 60201-1781, United States
Status: Recruiting
Clinical Trials Office - Evanston Hospital 847-570-1381

United States, Illinois
Ingalls Cancer Care Center at Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States
Status: Recruiting
Clinical Trials Office - Ingalls Cancer Care Center at Ingalls 708-915-6747

United States, Illinois
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, 60153, United States
Status: Recruiting
Clinical Trials Office - Cardinal Bernardin Cancer Center 708-226-4357

United States, Illinois
Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria, Illinois, 61615-7828, United States
Status: Recruiting
Sachdev P. Thomas, MD 309-243-1000 sthomas@ohaci.com

United States, Illinois
Central Illinois Hematology Oncology Center, Springfield, Illinois, 62701, United States
Status: Recruiting
Edem S. Agamah, MD, MS 217-525-2500 ihdn@aol.com

United States, Indiana
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, 46885-5099, United States
Status: Recruiting
David F. Sciortino, MD 260-484-8830

United States, Indiana
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, 46601, United States
Status: Recruiting
David A. Taber, MD 574-647-3353

United States, Michigan
Oncology Care Associates, PLLC, Saint Joseph, Michigan, 49085, United States
Status: Recruiting
Eric P. Lester, MD 269-985-0029

United States, Pennsylvania
Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033-0850, United States
Status: Recruiting
Clinical Trials Office - Penn State Cancer Institute at Milton 717-531-3779 CTO@hmc.psu.edu

United States, Wisconsin
Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, 53226, United States
Status: Recruiting
Clinical Trials Office - Medical College of Wisconsin Cancer C 414-805-4380

Canada, Ontario
Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada
Status: Recruiting
Natasha Leighl, MD, FRCPC 416-946-2399

Last modified: July 29 2010.